Perelman School of Medicine

Scavenger Hunt and Good Deed Pays Off for Contestants

May 4, 2012

Raina Merchant of the Perelman School of Medicine is quoted about the My Heart Map Challenge.

Article Source: Newsworks

Q&A With Garret FitzGerald, Univ. of Pennsylvania Expert on Drugs and Heart Risks

May 7, 2012

Garret FitzGerald of the Perelman School of Medicine is interviewed.

Article Source: Philly.com

Gene Therapy Safe in Decade-Long HIV Study That May Widen Use

May 2, 2012

Bruce Levine and Carl June of the Perelman School of Medicine are highlighted for their gene therapy research.

Article Source: Business Week

200 Years of Surgery: Cutting to Cure Has Come a Long Way

May 3, 2012

Bert O’Malley of the Perelman School of Medicine comments on using a miniature robotic arm to assist in minimally invasive surgeries.

Article Source: ABC News

How Do Controversial Revisions in Psychiatry’s Guidebook Make You Feel?

May 4, 2012

Mahendra Bhati of the Perelman School of Medicine is mentioned for leading the Penn field trial of the DSM-5.

Article Source: Philly.com

Video: The Tanning Mom: A Case of ‘Tanorexia’?

May 3, 2012

David Sarwer of the Perelman School of Medicine suggests that the mother accused of allowing her young daughter to use tanning beds might have body dismorphic disorder.

Article Source: 6ABC

UPenn Contest Winners Relied on Shoe Leather to Find Defibrillators

May 4, 2012

Winners of Penn’s MyHeartMap Challenge, led by Raina Merchant of the Perelman School of Medicine, are featured.

Article Source: Philly.com

Science in Court: Arrested Development

April 18, 2012

Stephen Morse of the Law School and the Perelman School of Medicine comments on the hazards of misusing scientific terms in court that might have different meanings.

Article Source: Nature.com
facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658May 3, 2012

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659May 2, 2012

Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients

HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.